BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 33095879)

  • 1. The Menopause Transition: Signs, Symptoms, and Management Options.
    Santoro N; Roeca C; Peters BA; Neal-Perry G
    J Clin Endocrinol Metab; 2021 Jan; 106(1):1-15. PubMed ID: 33095879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH
    Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal and nonhormonal treatment of vasomotor symptoms.
    Krause MS; Nakajima ST
    Obstet Gynecol Clin North Am; 2015 Mar; 42(1):163-79. PubMed ID: 25681847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.
    Alexander JL; Burger H; Dennerstein L; Woods NF; Davis SR; Kotz K; Van Winkle J; Richardson G; Ratka A; Kessel B
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S115-37. PubMed ID: 18039061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
    Deecher DC; Dorries K
    Arch Womens Ment Health; 2007; 10(6):247-57. PubMed ID: 18074100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia.
    Yisma E; Eshetu N; Ly S; Dessalegn B
    BMC Womens Health; 2017 Dec; 17(1):124. PubMed ID: 29216870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.
    NIH Consens State Sci Statements; 2005 Mar 21-23; 22(1):1-38. PubMed ID: 17308548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vegans report less bothersome vasomotor and physical menopausal symptoms than omnivores.
    Beezhold B; Radnitz C; McGrath RE; Feldman A
    Maturitas; 2018 Jun; 112():12-17. PubMed ID: 29704911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause.
    Potter B; Schrager S; Dalby J; Torell E; Hampton A
    Prim Care; 2018 Dec; 45(4):625-641. PubMed ID: 30401346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrinology of menopause.
    Edwards BJ; Li J
    Periodontol 2000; 2013 Feb; 61(1):177-94. PubMed ID: 23240949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of perimenopausal and menopausal symptoms.
    Duralde ER; Sobel TH; Manson JE
    BMJ; 2023 Aug; 382():e072612. PubMed ID: 37553173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
    Gartoulla P; Worsley R; Bell RJ; Davis SR
    Menopause; 2015 Jul; 22(7):694-701. PubMed ID: 25706184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
    Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the Vasomotor Symptoms of Menopause: Twofers in Your Clinical Toolbox.
    Kling JM; Stuenkel CA; Faubion SS
    Mayo Clin Proc; 2024 Jul; 99(7):1142-1148. PubMed ID: 38960498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing vasomotor symptoms effectively without hormones.
    McCormick CA; Brennan A; Hickey M
    Climacteric; 2020 Dec; 23(6):532-538. PubMed ID: 32696683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE; Chedraui P; Baron G; Belzares E; Bencosme A; Calle A; Danckers L; Espinoza MT; Flores D; Gomez G; Hernandez-Bueno JA; Izaguirre H; Leon-Leon P; Lima S; Mezones-Holguin E; Monterrosa A; Mostajo D; Navarro D; Ojeda E; Onatra W; Royer M; Soto E; Tserotas K; Vallejo S;
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal transition and depression: who is at risk and how to treat it?
    Soares CN
    Expert Rev Neurother; 2007 Oct; 7(10):1285-93. PubMed ID: 17939767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
    Gartoulla P; Worsley R; Bell RJ; Davis SR
    Menopause; 2018 Nov; 25(11):1331-1338. PubMed ID: 30358730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical challenges of perimenopause: consensus opinion of The North American Menopause Society.
    Menopause; 2000; 7(1):5-13. PubMed ID: 10646698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migraine headache in perimenopausal and menopausal women.
    MacGregor EA
    Curr Pain Headache Rep; 2009 Oct; 13(5):399-403. PubMed ID: 19728968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.